Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens.

Delville M, Lamarthée B, Pagie S, See SB, Rabant M, Burger C, Gatault P, Giral M, Thaunat O, Arzouk N, Hertig A, Hazzan M, Matignon M, Mariat C, Caillard S, Kamar N, Sayegh J, Westeel PF, Garrouste C, Ladrière M, Vuiblet V, Rivalan J, Merville P, Bertrand D, Le Moine A, Van Huyen JPD, Cesbron A, Cagnard N, Alibeu O, Satchell SC, Legendre C, Zorn E, Taupin JL, Charreau B, Anglicheau D.

J Am Soc Nephrol. 2019 Apr;30(4):692-709. doi: 10.1681/ASN.2018080868. Epub 2019 Mar 8.

PMID:
30850439
2.

Plasmacytoma-like post-kidney-transplant lymphoproliferative disorder confined to renal allograft and urinary tract: A case report.

Thibaud V, Rivalan J, Llamas F, Cherel M, Decaux O, Vigneau C.

Nephrol Ther. 2018 Dec;14(7):544-547. doi: 10.1016/j.nephro.2018.07.404. Epub 2018 Oct 6.

PMID:
30301610
3.

Recurrence of Renal Cell Cancer After Renal Transplantation in a Multicenter French Cohort.

Cognard N, Anglicheau D, Gatault P, Girerd S, Essig M, Hurault de Ligny B, Le Meur Y, Le Roy F, Garrouste C, Thierry A, Colosio C, Rivalan J, Sayegh J, Choukroun G, Moulin B, Caillard S.

Transplantation. 2018 May;102(5):860-867. doi: 10.1097/TP.0000000000002009.

PMID:
29215458
4.

A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders.

Caillard S, Cellot E, Dantal J, Thaunat O, Provot F, Janbon B, Buchler M, Anglicheau D, Merville P, Lang P, Frimat L, Colosio C, Alamartine E, Kamar N, Heng AE, Durrbach A, Moal V, Rivalan J, Etienne I, Peraldi MN, Moreau A, Moulin B; French PTLD Registry.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1663-1670. doi: 10.2215/CJN.03790417. Epub 2017 Aug 17.

5.

Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study.

Gatault P, Kamar N, Büchler M, Colosio C, Bertrand D, Durrbach A, Albano L, Rivalan J, Le Meur Y, Essig M, Bouvier N, Legendre C, Moulin B, Heng AE, Weestel PF, Sayegh J, Charpentier B, Rostaing L, Thervet E, Lebranchu Y.

Am J Transplant. 2017 May;17(5):1370-1379. doi: 10.1111/ajt.14109. Epub 2017 Jan 3.

6.

Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomes.

Garrouste C, Anglicheau D, Kamar N, Bachelier C, Rivalan J, Pereira B, Caillard S, Aniort J, Gatault P, Soubrier M, Sayegh J, Colosio C, Buisson A, Thervet E, Bouvier N, Heng AE.

Medicine (Baltimore). 2016 Oct;95(41):e5108.

7.

Rituximab for Recurrence of Primary Focal Segmental Glomerulosclerosis After Kidney Transplantation: Clinical Outcomes.

Garrouste C, Canaud G, Büchler M, Rivalan J, Colosio C, Martinez F, Aniort J, Dudreuilh C, Pereira B, Caillard S, Philipponnet C, Anglicheau D, Heng AE.

Transplantation. 2017 Mar;101(3):649-656. doi: 10.1097/TP.0000000000001160.

PMID:
27043407
8.

Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study.

Dury S, Colosio C, Etienne I, Anglicheau D, Merieau E, Caillard S, Rivalan J, Thervet E, Essig M, Babinet F, Subra JF, Toubas O, Rieu P, Launois C, Perotin-Collard JM, Lebargy F, Deslée G; Spiesser group.

BMC Pulm Med. 2015 Nov 7;15:141. doi: 10.1186/s12890-015-0133-9.

9.

Eight-year results of the Spiesser study, a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation.

Gatault P, Bertrand D, Büchler M, Colosio C, Hurault de Ligny B, Weestel PF, Rerolle JP, Thierry A, Sayegh J, Moulin B, Snanoudj R, Rivalan J, Heng AE, Sautenet B, Lebranchu Y.

Transpl Int. 2016 Jan;29(1):41-50. doi: 10.1111/tri.12656.

10.

Long-term results of combined liver-kidney transplantation for primary hyperoxaluria type 1: the French experience.

Compagnon P, Metzler P, Samuel D, Camus C, Niaudet P, Durrbach A, Lang P, Azoulay D, Duvoux C, Bayle F, Rivalan J, Merville P, Pascal G, Thervet E, Bensman A, Rostaing L, Deschenes G, Morcet J, Feray C, Boudjema K.

Liver Transpl. 2014 Dec;20(12):1475-85. doi: 10.1002/lt.24009.

11.

Suspicion of interaction between maribavir and everolimus in a renal transplant recipient.

Verdier MC, Patrat-Delon S, Lemaitre F, Revest M, Rivalan J, Michelet C, Bellissant E.

Transplantation. 2014 Aug 15;98(3):e20-1. doi: 10.1097/TP.0000000000000275. No abstract available.

PMID:
25089341
12.

CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.

Rabot N, Büchler M, Foucher Y, Moreau A, Debiais C, Machet MC, Kessler M, Morelon E, Thierry A, Legendre C, Rivalan J, Kamar N, Dantal J.

Transpl Int. 2014 Sep;27(9):956-65. doi: 10.1111/tri.12375. Epub 2014 Aug 20.

13.

Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance.

Guitard J, Hebral AL, Fakhouri F, Joly D, Daugas E, Rivalan J, Guigonis V, Ducret F, Presne C, Pirson Y, Hourmant M, Glachant JC, Vendrely B, Moranne O, Faguer S, Chauveau D.

Nephrol Dial Transplant. 2014 Nov;29(11):2084-91. doi: 10.1093/ndt/gfu209. Epub 2014 Jun 11.

PMID:
24920841
14.

Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.

Caillard S, Porcher R, Provot F, Dantal J, Choquet S, Durrbach A, Morelon E, Moal V, Janbon B, Alamartine E, Pouteil Noble C, Morel D, Kamar N, Buchler M, Mamzer MF, Peraldi MN, Hiesse C, Renoult E, Toupance O, Rerolle JP, Delmas S, Lang P, Lebranchu Y, Heng AE, Rebibou JM, Mousson C, Glotz D, Rivalan J, Thierry A, Etienne I, Moal MC, Albano L, Subra JF, Ouali N, Westeel PF, Delahousse M, Genin R, Hurault de Ligny B, Moulin B.

J Clin Oncol. 2013 Apr 1;31(10):1302-9. doi: 10.1200/JCO.2012.43.2344. Epub 2013 Feb 19.

PMID:
23423742
15.

[Acquired copper deficiency myelopathy].

Videt-Gibou D, Belliard S, Rivalan J, Ménard D, Edan G.

Rev Neurol (Paris). 2010 Jun-Jul;166(6-7):639-43. doi: 10.1016/j.neurol.2009.10.017. Epub 2010 May 13. French.

PMID:
20466396
16.

Iron excess treatable by copper supplementation in acquired aceruloplasminemia: a new form of secondary human iron overload?

Videt-Gibou D, Belliard S, Bardou-Jacquet E, Troadec MB, Le Lan C, Jouanolle AM, Loréal O, Rivalan J, Brissot P.

Blood. 2009 Sep 10;114(11):2360-1. doi: 10.1182/blood-2009-06-226175. No abstract available.

17.

Stent-graft repair for aortic type B dissections with insidious renal malperfusion.

De Latour B, Delaunay R, Rivalan J, Heautot JF, Verhoye JP.

J Thorac Cardiovasc Surg. 2007 Nov;134(5):1342-3. No abstract available.

18.

Management of vascular access for hemodialysis after successful kidney transplantation.

Patard JJ, Bensalah K, Lucas A, Rodriguez A, Manunta A, Rivalan J, Le Pogamp P, Lobel B, Guillé F.

Scand J Urol Nephrol. 2002;36(5):373-6.

PMID:
12487743
19.

Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression.

Mourad G, Garrigue V, Squifflet JP, Besse T, Berthoux F, Alamartine E, Durand D, Rostaing L, Lang P, Baron C, Glotz D, Antoine C, Vialtel P, Romanet T, Lebranchu Y, Al Najjar A, Hiesse C, Potaux L, Merville P, Touraine JL, Lefrancois N, Kessler M, Renoult E, Pouteil-Noble C, Cahen R, Legendre C, Bedrossian J, Le Pogamp P, Rivalan J, Olmer M, Purgus R, Mignon F, Viron B, Charpentier B.

Transplantation. 2001 Sep 27;72(6):1050-5.

PMID:
11579299
20.

[Immunosuppression, ongoing clinical trials].

Rivalan J.

Presse Med. 2001 Sep 1;30(24 Pt 2):38-40. French.

PMID:
11577587
21.

[Natural history of vascular ports for hemodialysis after renal transplantation].

Bensalah K, Guillé F, Rivalan J, Joyeux V, Gié S, Laruelle E, Garry J, Morin MP, Le Pogamp P, Lobel B, Patard JJ.

Prog Urol. 2001 Apr;11(2):231-4. French.

PMID:
11400483
22.

Contribution of 99Tcm-DMSA scintigraphy to aetiological diagnosis in renal transplant recipients with impaired renal function.

Garin E, Devillers A, Rivalan J, Girault S, Moisan A, Le Cloirec J, Bourguet P.

Nucl Med Commun. 2000 Jan;21(1):77-81.

PMID:
10717906
23.

[Polyradiculoneuropathy in an adult with primitive hyperoxaluria].

Furby A, Mourtada R, Charasse C, Rivalan J, Messner M, Leroy JP.

Rev Neurol (Paris). 2000 Jan;156(1):62-4. French.

PMID:
10693261
24.

Idiopathic retroperitoneal fibrosis and HLA antigens.

Chevet D, Rivalan J, Rebibou JM, Michel F, Guignier F.

Nephron. 1996;73(3):495. No abstract available.

25.

[Calcified intertrigo, a rare cause of cutaneous calcinosis].

Benkalfate L, Zein K, le Gall F, Chevrant-Breton J, Rivalan J, le Pogamp P.

Ann Dermatol Venereol. 1995;122(11-12):789-92. French.

PMID:
8729828
26.

Serum lipoprotein (a) in renal transplant recipients treated with cyclosporin monotherapy compared to conventional treatment.

Islam MS, Bard JM, Le Pogamp P, Leglise D, Bourbigot B, Rivalan J, Cledes J.

Nephrol Dial Transplant. 1994;9(3):332-3. No abstract available.

PMID:
8052449
27.

[Acute kidney failure due to tubulo-interstitial nephropathy after treatment with ciprofloxacin].

Arvieux C, Charasse C, Guilhem I, Rivalan J, Le Pogamp P, Ramée MP.

Presse Med. 1991 Oct 26;20(34):1686. French. No abstract available.

PMID:
1836581
28.

[Acute renal insufficiency caused by tubulo-interstitial nephropathy after treatment with ciprofloxacin].

Arvieux C, Charasse C, Guilhem I, Rivalan J, Le Pogamp P, Ramée MP.

Ann Med Interne (Paris). 1991;142(7):554-6. Review. French. No abstract available.

PMID:
1789537
29.

[Neurotoxicity of acyclovir in peritoneal dialysis apropos of 1 case].

Guilhem I, Charasse C, Gary J, Gie S, Rivalan J, Le Pogamp P, Beneton C, Lokiec F.

Nephrologie. 1991;12(5):241-3. French.

PMID:
1766532
30.

[Anti-basement-membrane antibody mediated, rapidly progressive, glomerulonephritis. Diagnostic and therapeutic strategy based on a retrospective study of 14 cases].

Bouget J, Le Pogamp P, Perrier G, Ramée MP, Rivalan J, Camus C, Thomas R, Chevet D.

Ann Med Interne (Paris). 1990;141(5):409-15. Review. French.

PMID:
2256583
31.

[Worsening of tubular hyperkalemia by corticosteroids in a patient with lupus].

Rivalan J, Chevet D, Le Pogamp P, Joyeux V, Charasse C.

Presse Med. 1989 Dec 2;18(40):1977. French. No abstract available.

PMID:
2531886
32.

Cyclosporin in idiopathic steroid-resistant membranous glomerulonephritis.

Rostoker G, Toro L, Ben Maadi A, Ryckelynk J, Sadreux T, Rivalan J, Chevet D, Janin C, Lang P, Weil B, et al.

Lancet. 1989 Oct 21;2(8669):975-6. No abstract available.

PMID:
2571881
33.

Predictive factors of the blood pressure fall induced by intravenous nicardipine.

Cluzel P, Chatellier G, Rivalan J, Bellet M, Corvol P, Menard J.

J Cardiovasc Pharmacol. 1989 Mar;13(3):370-5.

PMID:
2471881
34.

[Renal lithiasis, a logical complication of long-term treatment of glaucoma with a carbonic anhydrase inhibitor].

Rivalan J, Chevet D, Le Pogamp P, Charasse C, Joyeux V.

Ann Med Interne (Paris). 1989;140(5):419-20. French. No abstract available.

PMID:
2596788
35.

[Unusual metabolic alkalosis in chronic renal failure].

Thoreux PH, Chevet D, Le Pogamp P, Gie S, Rivalan J.

Ann Med Interne (Paris). 1986;137(7):601-2. French. No abstract available.

PMID:
3813304
36.

[Treatment of venous thromboembolic disease].

Laurent M, Rivalan J.

Soins Cardiol. 1985 Oct;(32):20-3. French. No abstract available.

PMID:
3853313

Supplemental Content

Loading ...
Support Center